Antimicrobial susceptibility and pneumococcal serotypes

Journal of Antimicrobial Chemotherapy

Volumn 50, Issue SUPPL. 2, 2002, Pages 13-19

  Fenoll, Asunción ^a   Asensio, Gema ^a   Jado, Isabel ^a   Berrón, Sonsoles ^a   Camacho, Maria Teresa ^a   Ortega, Montserrat ^a   Casal, Julio ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CHLORAMPHENICOL; ERYTHROMYCIN; LEVOFLOXACIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; TETRACYCLINE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHILD; CONTROLLED STUDY; DRUG CONJUGATION; FREQUENCY ANALYSIS; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PREVALENCE; REVIEW; SEROEPIDEMIOLOGY; SEROTYPE; SPAIN; STREPTOCOCCUS PNEUMONIAE; TIME; VACCINATION;

DRUG RESISTANCE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 0036986610     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkf509     Document Type: Review

References (20)

1. Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Lexau, C., Reingold, A. et al. (2000). Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in United States. New England Journal of Medicine 343, 1917-24.
2. Jettè L. P., Delage, G., Ringuette, L., Allard, R., De Wals, P., Lamothe, F. et al. (2001). Surveillance of invasive Streptococcus pneumoniae infection in the province of Quebec, Canada, from 1996 to 1998: serotype distribution, antimicrobial susceptibility, and clinical characteristics. Journal of Clinical Microbiology 39, 733-7.
3. Di Fabio, J. L., Castañeda, E., Agudelo, C. I., De la Hoz, F., Hortal, M., Camou, T. et al. (2001). Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigía Group, 1993 to 1999. Pediatric Infectious Disease Journal 20, 959-67.
4. Verhaegen, J., Van de Ven, J., Verbiest, N., Van Eldere, J. & Verbist, L. (2000). Evolution of Streptococcus pneumoniae serotypes and antibiotic resistence in Belgium-Update (1994-98). Clinical Microbiology and Infection 6, 308-15.
5. Reinert, R. R., Simic, S., Al-lahham, A., Reinert, S., Lemperle, M. & Lütticken, R. (2001). Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients with respiratory tract infections in Germany from 1998 to 1999: Results of a national surveillance study. Journal of Clinical Microbiology 39, 1187-9.
6. Black, S., Shinefield, H., Fireman, B., Lewis, F., Ray, P., Hansen, J. R. et al. (2000). Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Paediatric Infectious Disease Journal 19, 187-95.
7. Dagan, R., Melamed, R., Muallen, M., Piglansky, L., Greenberg, D., Abramson, O. et al. (1996). Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. Journal of Infectious Diseases 174, 1271-8.
8. Dagan, R. & Fraser, D. (2000). Conjugate pneumococcal vaccine and antibiotic-resistant Streptococcus pneumoniae: herd immunity and reduction of otitis morbidity. Pediatric Infectious Disease Journal 19, Suppl., S79-88.
9. Spratt, B. G. & Greenwood, B. M. (2000). Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet 356, 1210-1.
10. Fenoll, A., Jado, I., Vicioso, D. & Casal, J. (1997). Dot blot assay for the serotyping of pneumococci. Journal of Clinical Microbiology 35, 764-6.
11. Fenoll, A., Martín-Bourgon, C., Muñoz, R., Vicioso, D., & Casal, J. (1991). Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing systemic infections in Spain, 1979-1989. Reviews of Infectious Diseases 13, 56-60.
12. National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard M7-A5. Wayne, PA, USA.
13. Fenoll, A., Jado, I., Vicioso, D., Pérez, A. & Casal, J. (1998). Evolution of Streptococcus pneumoniae serotypes and antibiotic resistance in Spain: update (1990-1996). Journal of Clinical Microbiology 36, 3447-54.
14. Thomas, M. F. (2002). Appropriate use of antimicrobials for drug-resistant pneumonia: focus on the significance of β-lactam-resistant Streptococcus pneumoniae. Clinical Infectious Diseases 34, S17-26.
15. Gomez-Barreto, D., Calderon-Jaimes, E., Rodríguez, R. S. & de los Monteros, L. E. (2000). Clinical outcome of invasive infections in children caused by highly penicillin-resistant Streptococcus pneumoniae compared with infections caused by penicillin-susceptible strains. Archives of Medical Research 31, 592-8.
16. Garau, J. (2001). The hidden impact of antibacterial resistance in respiratory tract infection. Clinical failures: the tip of an iceberg? Respiratory Medicine 95, Suppl, A, S5-11; S26-7.
17. Empey, P. E., Jenning, H. R., Thornton, A. C., Rapp, R. P. & Evans, M. E. (2001). Levofloxacin failure in a patient with pneumococcal pneumonia. Annals of Pharmacotherapy 35, 687-90.
18. Kelly, M. A., Weber, D. J., Gilligan, P. & Cohen, M. S. (2000). Breakthrough pneumococcal bacteremia in patients being treated with azithromycin and clarithromycin. Clinical Infectious Diseases 31, 1008-11.
19. Chen, D. K., McGeer, A., de Azavedo, J. C. & Low, D. E. (1999). Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. New England Journal of Medicine 341, 233-9.
20. Liñares, J., De la Campa, A. G. & Pallares, R. (1999). Fluoroquinolone resistance in Streptococcus pneumoniae. New England Journal of Medicine 341, 1546-7.